A $4-billion acquisition, a key finding for sarcopenia drug development, and algorithmic efficiency… What’s new in advanced medicine?

What lies beyond COVID-19? There are many diseases that could benefit from all the collaborative effort and funding being poured into COVID-19.

What biosecurity risks do exo-microorganisms pose?

A look at the past, present, and future of vaccine production – and how COVID-19 changes the outlook.

NASA ultimately wants to send humans to Mars – and those humans will need medicines.

A step closer to an off-the-shelf CAR T cell therapy.

How do we make medicines in space? Lynn J. Rothschild explains how biologic medicines can be made on demand.

Are seriously ill patients vulnerable to overestimating the benefits and underestimating the risks of gene editing studies?

Ross Burn presents the story behind his career, including setting up a company on process chemistry and his views on industry 4.0.

Implementing green practices in clinical trials.